Publication | Closed Access
Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
45
Citations
33
References
2016
Year
Doxorubicin ResistanceOncologyMedicineHypoxia (Medicine)ImmunologyP-gp ExpressionAnti-cancer AgentPharmacologyLung CancerP-gp Blockers
| Year | Citations | |
|---|---|---|
Page 1
Page 1